Hee Jae Huh1, Chang-Seok Ki2, Sun Ae Yun3, Jungsoo Lee4, Gwi Young Oh4, Nam-Sihk Lee4, Young Ho Yoon4, Nam Yong Lee1. 1. Department of Laboratory Medicine and Genetics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea. 2. Green Cross Genome, Yongin, South Korea. 3. Center for Clinical Medicine, Samsung Biomedical Research Institute, Samsung Medical Center, Seoul, Korea. 4. Eone Laboratories, Incheon, Korea.
Abstract
BACKGROUND: The DiaPlexQ™ STI6 Detection Kit (DiaPlexQ; Solgent Co., Ltd., Daejeon, South Korea) is a multiplex real-time PCR assay for the detection of the following sexually transmitted disease (STD) pathogens: Chlamydia trachomatis, Neisseria gonorrhoeae, Mycoplasma hominis, Trichomonas vaginalis, Ureaplasma urealyticum, and Mycoplasma genitalium. We compared the performance of the DiaPlexQ assay with the GeneFinder™ STD I (CT/NG/UU) and STD II (MG/MH/TV) Multiplex Real-time PCR Kits (GeneFinder; Infopia Co., Ltd., Anyang, South Korea). METHODS: We evaluated the performance of the DiaPlexQ assay in comparison to that of GeneFinder using 1106 clinical specimens (542 genital swabs and 564 urine samples). The analytical performance of the DiaPlexQ assay, including the limit of detection (LOD) and analytical specificity, was evaluated using reference strains. RESULTS: The positive percent agreement, negative percent agreement, and kappa value between the two assays were 96.6%-99.4%, 98.2%-99.8%, and 0.93%-0.99%, respectively. No cross-reactivity was observed in a collection of 41 different microorganisms and the LOD of the DiaPlexQ assay ranged from 1 to 10 copies/reaction for each microorganism. CONCLUSION: The DiaPlexQ assay showed comparable performance to that of the GeneFinder assay so that it can be used for the screening and diagnosis of non-viral curable STD pathogens.
BACKGROUND: The DiaPlexQ™ STI6 Detection Kit (DiaPlexQ; Solgent Co., Ltd., Daejeon, South Korea) is a multiplex real-time PCR assay for the detection of the following sexually transmitted disease (STD) pathogens: Chlamydia trachomatis, Neisseria gonorrhoeae, Mycoplasma hominis, Trichomonas vaginalis, Ureaplasma urealyticum, and Mycoplasma genitalium. We compared the performance of the DiaPlexQ assay with the GeneFinder™ STD I (CT/NG/UU) and STD II (MG/MH/TV) Multiplex Real-time PCR Kits (GeneFinder; Infopia Co., Ltd., Anyang, South Korea). METHODS: We evaluated the performance of the DiaPlexQ assay in comparison to that of GeneFinder using 1106 clinical specimens (542 genital swabs and 564 urine samples). The analytical performance of the DiaPlexQ assay, including the limit of detection (LOD) and analytical specificity, was evaluated using reference strains. RESULTS: The positive percent agreement, negative percent agreement, and kappa value between the two assays were 96.6%-99.4%, 98.2%-99.8%, and 0.93%-0.99%, respectively. No cross-reactivity was observed in a collection of 41 different microorganisms and the LOD of the DiaPlexQ assay ranged from 1 to 10 copies/reaction for each microorganism. CONCLUSION: The DiaPlexQ assay showed comparable performance to that of the GeneFinder assay so that it can be used for the screening and diagnosis of non-viral curable STD pathogens.
Authors: M C Little; J Andrews; R Moore; S Bustos; L Jones; C Embres; G Durmowicz; J Harris; D Berger; K Yanson; C Rostkowski; D Yursis; J Price; T Fort; A Walters; M Collis; O Llorin; J Wood; F Failing; C O'Keefe; B Scrivens; B Pope; T Hansen; K Marino; K Williams Journal: Clin Chem Date: 1999-06 Impact factor: 8.327
Authors: Magnus Unemo; Catriona S Bradshaw; Jane S Hocking; Henry J C de Vries; Suzanna C Francis; David Mabey; Jeanne M Marrazzo; Gerard J B Sonder; Jane R Schwebke; Elske Hoornenborg; Rosanna W Peeling; Susan S Philip; Nicola Low; Christopher K Fairley Journal: Lancet Infect Dis Date: 2017-07-09 Impact factor: 25.071
Authors: Charlotte A Gaydos; Barbara Van Der Pol; Mary Jett-Goheen; Mathilda Barnes; Nicole Quinn; Carey Clark; Grace E Daniel; Paula B Dixon; Edward W Hook Journal: J Clin Microbiol Date: 2013-03-06 Impact factor: 5.948
Authors: Remco P H Peters; Lindsey de Vos; Liteboho Maduna; Maanda Mudau; Jeffrey D Klausner; Marleen M Kock; Andrew Medina-Marino Journal: J Clin Microbiol Date: 2017-10-11 Impact factor: 5.948